DIABETIC MACULAR EDEMA (DME)
Clinical trials for DIABETIC MACULAR EDEMA (DME) explained in plain language.
Never miss a new study
Get alerted when new DIABETIC MACULAR EDEMA (DME) trials appear
Sign up with your email to follow new studies for DIABETIC MACULAR EDEMA (DME), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New dosing strategy could mean fewer eye injections for Diabetes-Related vision loss
Disease control Not yet recruitingThis study tests whether a treat-and-extend schedule for aflibercept eye injections works better than the standard as-needed approach for people with diabetic macular edema who have not had prior treatment. About 186 participants will receive three monthly injections, then either…
Matched conditions: DIABETIC MACULAR EDEMA (DME)
Phase: PHASE4 • Sponsor: The Third Peoples Hospital of Dalian • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a bile acid and herbal mix treat Diabetes-Related vision loss?
Disease control Not yet recruitingThis study tests whether two dietary supplements—tauroursodeoxycholate (a bile acid) and a traditional Chinese medicine formula—can help people with diabetic macular edema, a vision-threatening complication of diabetes. The 69 participants will take the supplements or a placebo f…
Matched conditions: DIABETIC MACULAR EDEMA (DME)
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New daily pill aims to save sight in diabetic eye disease
Disease control Not yet recruitingThis study tests an oral medication, CU06-1004, for people with diabetic macular edema (DME), a condition that causes vision loss. About 156 participants will take either a low dose, high dose, or placebo pill daily for 24 weeks. The goal is to see if the drug improves vision and…
Matched conditions: DIABETIC MACULAR EDEMA (DME)
Phase: PHASE2 • Sponsor: Curacle Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Two-Drug combo may boost vision in diabetic eye disease
Disease control Not yet recruitingThis study compares a combination of a steroid implant (dexamethasone) plus an anti-VEGF injection (aflibercept) against aflibercept alone for diabetic macular edema. Researchers will enroll 114 people with diabetes who have not had prior treatment. The goal is to see if the comb…
Matched conditions: DIABETIC MACULAR EDEMA (DME)
Phase: PHASE4 • Sponsor: Kun Liu • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Could one injection during cataract surgery prevent diabetic eye disease worsening?
Disease control Not yet recruitingThis study looks at whether a single injection of the drug Aflibercept given during cataract surgery works as well as three injections (one during surgery and two more over the next two months) to stop diabetic retinopathy from getting worse. The trial will include 166 diabetic p…
Matched conditions: DIABETIC MACULAR EDEMA (DME)
Phase: PHASE4 • Sponsor: Ahmad Zeeshan Jamil • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC